AFYREN

AFYREN is a notable biotech company, established in 2012, with a focus on producing high-value biobased compounds through a biomimetic fermentation process. Their flagship plant, AFYREN NEOXY, located in Carling Saint-Avold, France, is a unique, low-carbon, zero-waste biorefinery that manufactures 7 100% biobased acids through a short-circuit production approach, positioning them strategically within the heart of Europe. Their solutions cater to a wide array of industries including food, cosmetics, pharmaceuticals, chemicals, and materials, collaborating with global partners to develop sustainable products tailored to market needs. The company's vision revolves around enabling a low-carbon, circular industry by providing biobased solutions. Their commitment to environmental sustainability is evident through their endeavors to minimize environmental footprint and maximize social and economic impact. With a strong emphasis on sustainable innovation and reinventing the chemical industry through bioeconomy, AFYREN presents an enticing proposition for investors looking to engage with forward-thinking biotech ventures. Overall, AFYREN's pioneering approach in the biotech industry, emphasis on sustainability, and strategic European location make it a compelling prospect for potential investors seeking opportunities in the biotechnology sector.